4 views left Get unlimited views with a free account

Take your business to the next level. Explore the latest trends and actionable insights to inform business strategy and pinpoint opportunities and risks.

Europe: Top Rare Diseases Patents Holders in the Healthcare Sector (2002 - 2022)

Industry: Healthcare Providers
Current: Other Industry Indicators

With 9,149 patents held between 2002 and 2022, Pfizer Inc holds the most number of Rare Diseases patents in the Healthcare sector in the Europe region.
The second largest number of patents were held by F. Hoffmann-La Roche Ltd with 6,700 Rare Diseases patents. The third largest number of patents were held by Sanofi with 5,507 Rare Diseases patents, of which 23.9% was contributed by Aventis Pharma SA. The fourth largest number of patents were held by Johnson & Johnson with 4,217 Rare Diseases patents, of which 50.4% was contributed by Janssen Pharmaceutica NV. The fifth largest number of patents were held by Novartis AG with 3,994 Rare Diseases patents.
The top five patents holders, i.e., Pfizer Inc, F. Hoffmann-La Roche Ltd, Sanofi, Johnson & Johnson, and Novartis AG, together held 29,567 Rare Diseases patents during the period.

Europe: Top Rare Diseases Patents Holders in the Healthcare Sector (2002 - 2022)

View as table

Take your business to the next level. Explore the latest trends and actionable insights to inform business strategy and pinpoint opportunities and risks. Take your business to the next level. Explore the latest trends and actionable insights to inform business strategy and pinpoint opportunities and risks. Visit Report Store